TP53 and invasive carcinoma: However, progression to invasive carcinoma appears to be absolutely dependent on p53 as its inactivation in β1 integrin-deficient mice completely restored tumour onset, penetrance, and tumour multiplicity to comparable levels as MIC WT counterparts (Fig. 5a, b).